SOVLEPLENIB IN PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) PATIENTS BY PRIOR LINES OF THERAPY: SUBGROUP ANALYSIS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY (ESLIM-01)
EHA Library, Xiaofan Liu,
419716
INCIDENCE, DESCRIPTION, AND MANAGEMENT OF VENOUS THROMBOSES IN ADULT PATIENTS WITH IMMUNE THROMBOCYTOPENIC PURPURA. RESULTS FROM THE MULTICENTER PROSPECTIVE REGISTRY CARMEN-FRANCE.
EHA Library, François THERME,
419717
SOVLEPLENIB IN PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) PTS WITH PRIOR TPO/TPO-RA TREATMENT: SUBGROUP ANALYSIS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY (ESLIM-01)
EHA Library, Heng Mei,
419718
LONG-TERM SAFETY AND EFFICACY OF RILZABRUTINIB, AN ORAL BRUTON TYROSINE KINASE INHIBITOR, IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP): INTEGRATED PHASE 2 PART A AND PART B
EHA Library, Nichola Cooper,
419722
INDIVIDUAL PHARMACOKINETIC EVALUATION OF FIXED-SEQUENCE SINGLE-DOSE OCTOCOG ALFA, RURIOCTOCOG ALFA PEGOL, AND EFANESOCTOCOG ALFA IN ADULTS WITH SEVERE HEMOPHILIA A
EHA Library, Jimenez Yuste Victor ,
419732
A NEW E-HEALTH TOOL TO PERSONALIZE CANCER CARE, BASED ON PROACTIVE PATIENTS’ NEEDS ASSESSMENT DURING AND AFTER TREATMENT: A DEVELOPMENTAL STUDY IN A HEMATOLOGICAL CARE PATHWAY, THE PROZORG-STUDY
EHA Library, Kon-Siong Jie,
419771
COST-EFFECTIVENESS ANALYSIS OF POLATUZUMAB VEDOTIN IN COMBINATION WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE (POLA + R-CHP) IN UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA IN DENMARK.
EHA Library, Christian Beck,
419786